The specific applications of rapid detection reagents for monkeypox virus are mainly reflected in the following aspects:

Clinical Diagnosis Assistance
In medical institutions, when patients present with suspected symptoms of monkeypox such as fever, rashes, and swollen lymph nodes, doctors can use rapid detection reagents for monkeypox virus to test samples from the patient’s skin lesions (such as blister fluid, scabs), blood, respiratory secretions, etc. The rapid detection reagent can provide test results in a relatively short time, helping doctors quickly determine whether the patient is infected with the monkeypox virus, so as to formulate treatment plans in a timely manner.
Differential Diagnosis
The symptoms of monkeypox are similar to those of other exanthematous diseases such as chickenpox and smallpox. The rapid detection reagent can accurately detect the specific antigens or nucleic acid sequences of the monkeypox virus, helping doctors distinguish monkeypox from other similar diseases and avoiding misdiagnosis and missed diagnosis.

Community Monitoring
During the prevalence of the monkeypox epidemic, rapid detection reagents can be used to screen people with suspected symptoms in crowded places such as communities, schools, and nursing homes. This allows for the timely identification of potential infected individuals, and the implementation of isolation and prevention measures to prevent the spread of the epidemic within the community.
Border Port Monitoring
At border ports, rapid detection of incoming travelers from monkeypox – epidemic areas can promptly identify imported cases, preventing the introduction of the monkeypox virus into the country through cross – border human movement and safeguarding domestic public health security.
Medical Institution Monitoring
In relevant departments of hospitals such as fever clinics and dermatology departments, the active monitoring of patients visiting the doctor using rapid detection reagents helps to promptly detect sporadic cases and clustered epidemics, providing an early warning for epidemic prevention and control.

Formulation of Epidemic Prevention and Control Strategies
Rapid and large – scale detection of the monkeypox epidemic through rapid detection reagents can promptly grasp key information such as the spread range, number of infected people, and epidemic trends. This provides a basis for governments and health departments to formulate scientific and reasonable epidemic prevention and control strategies, such as identifying key prevention and control areas and allocating medical resources.
Screening of Close Contacts
For close contacts of confirmed monkeypox cases, rapid detection reagents are used for testing. This can quickly determine whether close contacts are infected. Infected individuals can be isolated and treated in a timely manner, and medical observation measures can be taken for uninfected close contacts, effectively cutting off the virus transmission chain.

Research on Virus Transmission
When studying the transmission patterns and routes of the monkeypox virus, rapid detection reagents can be used to test different environmental samples (such as air, object surfaces) and animal samples. This helps researchers understand the survival and transmission capabilities of the virus in different environments, providing a scientific basis for formulating prevention and control measures.
Vaccine and Drug Research and Development
During the research and development of monkeypox vaccines and drugs, rapid detection reagents can be used to evaluate the immune effects of vaccines and the therapeutic effects of drugs. By testing animals or people after vaccination or drug use, observing indicators such as changes in viral load, it is possible to determine whether the vaccine or drug is effective, providing data support for the research and development work.